The Ca 2+-ATPase accounts for the majority of Ca 2+ removed from the cytoplasm during cardiac muscle relaxation. The Ca 2+-ATPase is regulated by phospholamban, a 52 amino acid phosphoprotein, which inhibits Ca 2+-ATPase activity by decreasing the apparent affinity of the ATPase for Ca 2+. To study the physical mechanism of Ca 2+-ATPase regulation by phospholamban using spectroscopic and kinetic experiments, large amounts of both proteins are required. Therefore, we developed a Ca 2+-ATPase and phospholamban preparation based on the baculovirus-insect cell expression system using High-Five insect cells to produce large amounts of microsomal vesicles that contain either Ca 2+-ATPase expressed alone or Ca 2+-ATPase co-expressed with phospholamban. The expressed proteins were characterized using immunofluorescence spectroscopy, Ca 2+-ATPase activity assays, Ca 2+ uptake and efflux assays, and Western blotting. Our purification method yields 140 mg of microsomal protein per liter of infection (1.7 × 10 9 cells), and the Ca 2+-ATPase and phospholamban account for 16 and 1.4%, respectively, of the total microsomal protein by weight, yielding a phospholamban:Ca 2+-ATPase ratio of 1.6:1, similar to that observed in native cardiac SR vesicles. The enzymatic properties of the expressed Ca 2+-ATPase are also similar to those observed in native cardiac SR vesicles, and when co-expressed with phospholamban, the Ca 2+-ATPase is functionally coupled to phospholamban similar to that observed in cardiac SR vesicles.
Read full abstract